Bio-Key International Inc (NASDAQ:BKYI) has a beta value of -0.00 and has seen 0.47 million shares traded in the recent trading session. The company, currently valued at $5.44M, closed the recent trade at $1.74 per share which meant it gained $0.2 on the day or 12.82% during that session. The BKYI stock price is -85.06% off its 52-week high price of $3.22 and 70.11% above the 52-week low of $0.52. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.24 million shares traded. The 3-month trading volume is 2.26 million shares.
Bio-Key International Inc (NASDAQ:BKYI) trade information
Sporting 12.82% in the green today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the BKYI stock price touched $1.74 or saw a rise of 24.02%. Year-to-date, Bio-Key International Inc shares have moved 1.60%, while the 5-day performance has seen it change -27.00%. Over the past 30 days, the shares of Bio-Key International Inc (NASDAQ:BKYI) have changed 53.75%. Short interest in the company has seen 0.87 million shares shorted with days to cover at 0.16.
Bio-Key International Inc (BKYI) estimates and forecasts
The company’s shares have gained 2.80% over the past 6 months.
1 analysts offering their estimates for the company have set an average revenue estimate of 2.29M for the current quarter. 1 have an estimated revenue figure of 2.5M for the next ending quarter.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 32.10% over the past 5 years.
BKYI Dividends
Bio-Key International Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Bio-Key International Inc (NASDAQ:BKYI)’s Major holders
Insiders own 5.57% of the company shares, while shares held by institutions stand at 9.26% with a share float percentage of 9.81%. Investors are also buoyed by the number of investors in a company, with Bio-Key International Inc having a total of 11.0 institutions that hold shares in the company.
